CAPTRUST Financial Advisors
SAGE

CAPTRUST Financial Advisors’s Sage Therapeutics SAGE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,596
Closed -$92.2K – 2586
2025
Q1 		$92.2K Buy
+11,596
New +$84.9K ﹤0.01% 2239
2023
Q3 		– Sell
-6,091
Closed -$286K – 2700
2023
Q2 		$286K Buy
6,091
+502
+9% +$25K ﹤0.01% 2013
2023
Q1 		$235K Buy
+5,589
New +$240K ﹤0.01% 1941
2022
Q3 		– Sell
-402
Closed -$13K – 3670
2022
Q2 		$13K Sell
402
-196
-33% -$6.57K ﹤0.01% 3617
2022
Q1 		$20K Buy
598
+368
+160% +$13.8K ﹤0.01% 3393
2021
Q4 		$10K Sell
230
-209
-48% -$8.75K ﹤0.01% 3722
2021
Q3 		$19K Sell
439
-89
-17% -$4.08K ﹤0.01% 3205
2021
Q2 		$30K Buy
528
+12
+2% +$848 ﹤0.01% 2842
2021
Q1 		$39K Sell
516
-387
-43% -$31.7K ﹤0.01% 2595
2020
Q4 		$78K Buy
903
+789
+692% +$58.2K ﹤0.01% 1628
2020
Q3 		$7K Hold
114
– – ﹤0.01% 2433
2020
Q2 		$5K Buy
+114
New +$4.14K ﹤0.01% 2398
2018
Q3 		– Sell
-4
Closed -$1K – 1682
2018
Q2 		$1K Sell
4
-9
-69% -$1.41K ﹤0.01% 1467
2018
Q1 		$2K Buy
+13
New +$2.21K ﹤0.01% 1252

Other funds holding SAGE

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

CAPTRUST Financial Advisors's SAGE Position: Q2 2025 in Review

CAPTRUST Financial Advisors sold out of Sage Therapeutics (SAGE) in Q2 2025, closing a stake of 11,596 shares — an estimated $92.2K sold.

CAPTRUST Financial Advisors first reported a position in SAGE in Q1 2018 and held it in 14 quarters. The position peaked at $286K in Q2 2023. 192 funds tracked by Wall St. Rank hold SAGE as of Q2 2025.

  • CAPTRUST Financial Advisors reported no remaining Sage Therapeutics position as of Q2 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 11,596 Sage Therapeutics shares in Q2 2025, an estimated $92.2K.
  • CAPTRUST Financial Advisors first reported a position in Sage Therapeutics in Q1 2018 and held it in 14 quarters.
  • CAPTRUST Financial Advisors's Sage Therapeutics position peaked at $286K in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.